Members-only Site   |   Print Page   |   Contact Us   |   Sign In   |   Register
IACP Foundation Research Funded
Share |
 
 

 

 

IACP Foundation FUnded Research


The IACP Foundation sought proposals for funding consideration from 2005-2015. Proposals were considered on a case-by-case basis and funding may have been awarded in whole or in part. The maximum amount per proposal has varied throughout the years, with most being a maximum of $10,000 per study.

 

Grant proposals have focused on the outcomes of treatment, potency, and stability of compounded preparations for humans and animals in an effort to provide more peer-reviewed compounded preparation information as seen below.

 

The IACP Foundation is no longer seeking proposals for funding consideration.  

 

 

RESEARCH INITIATIVES funded

The Research and Education Committee was formed in June 2004 to fulfill the IACP Foundation’s mission to advance the art and science of pharmacy compounding by funding research and public education initiatives within the profession. An 18-member volunteer committee worked diligently the first year to establish the priorities for giving and the application process.

Since 2005, the IACP Foundation has awarded more than $275,000 for studies researching compounded preparation potency and stability and outcomes of treatment with compounded medications. 

 

Open Projects:

EVALUATION OF THE PERCUTANEOUS ABSORPTION OF ABH GELS ACROSS PORCINE EAR AND HUMAN ABDOMINAL SKIN

Principal Investigators: Sai HS. Boddu, PhD, Assistant Professor, Department of Pharmacy Practice, The University of Toledo; Kenneth Alexander, PhD, Professor, Department of Pharmacy Practice, The University of Toledo; Matthew Frank, P2 PharmD Student, College of Pharmacy and Pharmaceutical Sciences, The University of Toledo

 

Click here for a related article abstract.

Click here for a related poster presentation.

 



Completed Projects:  

SYSTEMATIC REVIEW OF COMPOUNDED PREPARATIONS FOR NEUROPATHIC PAIN 

Principal Investigators: Meghana V. Aruru, Ph.D., MBA, B.Pharm and Melissa Hogan, Pharm.D.; Roosevelt University, College of Pharmacy

 

This grant is complete.  The data was insufficient and the primary investigator declined to publish results.

 

EXTENSION OF BEYOND USE DATES FOR COMBINATION TOPICAL PAIN MEDICATIONS 

Principal Investigator: Jwala Renukuntla, Ph.D., South College School of Pharmacy

 

This grant is complete and the primary investigator declined to publish results.

 

BEYOND-USE DATE (BUD) TESTING DATA ON ERECTILE DYSFUNCTION

Principal Investigator: Sarah Billings, PharmD, CDE: Director of Clinical Programs; Grove Pharmacy

 

This grant is complete.  The data was insufficient and the principal investigator declined to publish results.

 

STABILITY AND BEYOND-USE-DATE STUDIES FOR SIX COMMONLY PRESCRIBED AGENTS USED IN THE TRANSDERMAL TREATMENT OF CHRONIC PAIN

Principal Investigator: Curt R. Cyr, R.Ph., Ph.D., University of New England, College of Pharmacy

 

This grant is complete and the principal investigator declined to publish results.

 

TOPICAL KETAMINE IN THE TREATMENT OF COMPLEX REGIONAL PAIN SYNDROME 

 

Principal Investigators: Melissa J. Durham, PharmD, MACM, Assistant Professor Clinical Pharmacy, University of Southern California School of Pharmacy, Hovik S. Mekhjian, PharmD, Jeffery A. Goad, PharmD, MPH, Mimi Lou MS, Michelle Ding, PharmD, MS, and Steven H. Richeimer, MD

 

Click here to view the abstract. *Published in the International Journal of Pharmaceutical Compounding (IJPC) Mar / Apr 2018, Volume 22, Number 2: 172-175

 

SYSTEMATIC REVIEW OF PHARMACY COMPOUNDING OF PAIN MEDICATION

Principal Investigaor: Mohammed S. Shawqqfeh, PharmD, PhD,  NOVA Southeastern University, College of Pharmacy, Catherine Harrington, PharmD, PhD, NOVA Southeastern University, Lloyd L. Gregory School of Pharmacy

 

Click here to view the abstract. *Published in the International Journal of Pharmaceutical Compounding (IJPC) Jan / Feb 2018, Volume 22, Number 1: 19-24

 

STABILITY OF EXTEMPORANEOUSLY PREPARED PRESERVATIVE-FREE PROCHLORPERAZINE NASAL SPRAY

Principal Investigator: Venkata Kashyap Yellepeddi, Ph.D., Assistant Professor of Pharmaceutical Sciences, College of Pharmacy, Roseman University of Health Sciences

 

Click here to view the abstract. *Published in 

 

DEVELOPMENT AND APPLICATION OF A HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY STABILITY-INDICATING ASSAY FOR BEYOND-USE DATE DETERMINATION OF COMPOUNDED TOPICAL GELS CONTAINING MULTIPLE ACTIVE DRUGS

Principal Investigators: Greg Gorman, Ph.D., Simara Sokom, Lori Coward, and John Arnold, Ph.D., McWhorter School of Pharmacy, Samford University

 

Click here to view the abstract. *Published in the International Journal of Pharmaceutical Compounding (IJPC) Mar/Apr 2017, Volume 21, Number 2: 164-170

 

EVALUATION OF THE STABILITY OF MERCAPTOPURINE SUSPENSION COMPOUNDED IN A COMMERCIAL VEHICLE AND THE DETERMINATION OF AN APPROPRIATE BEYOND-USE DATE

Principal Investigators: Gina F. Peacock, PhD, Shenandoah University College of Pharmacy, Jurgita Sauvageot, PharmD, Ashley Hill, PharmD, Alyssa Killian, PharmD,


Click here to view the abstract. *Published in theInternational Journal of Pharmaceutical Compounding (IJPC) Jan/Feb 2016, Volume 20, Number 1: 81-85

 

PHARMACISTS’ PERCEPTIONS OF THE ECONOMIC VALUE OF COMPOUNDED PHARMACEUTICALS: A COMPARISON OF COMPOUNDED AND COMMERCIAL PHARMACEUTICALS IN SELECT DISEASE STATES

Principal Investigators: William B. Lobb, RPh, PhD, Noel E. Wilkin, RPh, PhD, Erin R. Holmes, PharmD, PhD


Click here to view the abstract. *Published in theInternational Journal of Pharmaceutical Compounding (IJPC) Nov/Dec 2015, Volume 19, Number 6: 514-520

 

SOLID-STATE STABILITY OF COMPOUNDED LEVOTHYROXINE FORMULATIONS

Principal Investigators: Deepa A. Rao, PhD; Assistant Professor; Jeff Fortner, RPh, PharmD; Assistant Professor; Pacific University School of Pharmacy

 

Click here to view the abstract. *Published in theInternational Journal of Pharmaceutical Compounding (IJPC) Sept/Oct 2015, Volume 19, Number 5: 414-419

 

DEVELOPMENT AND VALIDATION OF AN INEXPENSIVE, SIMPLE, AND RAPID TECHNIQUE FOR MEASURING THE ACCURACY OF EXTEMPORANEOUSLY COMPOUNDED PHARMACEUTICALS

Principal Investigators: Claudia Meek, PhD; Andrew Rothardt; Jason Evans, PharmD; Rosanne Thurman, PharmD; Lisa D. Ashworth, BS Pharm, RPh; Richard Leff, PharmD

 

Click here to view the abstract. *Published in theInternational Journal of Pharmaceutical Compounding (IJPC) Jul/Aug 2015, Volume 19, Number 4: 340-343

 

SKIN PENETRATION AND ANTINOCICEPTION OF TOPICAL GABAPENTIN FORMULATIONS

Principal Investigators: Scott Asbill, PhD, Professor of Pharmaceutics and Chair, Department of Pharmaceutical and Administrative Sciences, Presbyterian College School of Pharmacy; Evan Bryson; Sarah Sweitzer, PhD

 

Click here to view the abstract. *Published in theInternational Journal of Pharmaceutical Compounding (IJPC) Nov/Dec 2014, Volume 18, Number 6: 504-511

 

IMPACT OF THE CHEMICAL AND PHYSICAL STABILITY OF KETOPROFEN COMPOUNDED IN VARIOUS PHARMACEUTICAL BASES ON ITS TOPICAL AND TRANSDERMAL DELIVERY

Principal Investigators: Adwoa O. Nornoo, PhD, Associate Professor of Pharmaceutical Sciences, Palm Beach Atlantic University; Jordan Wulz; Haena Yoon; Yu Nan; Michele Lese

 

Click here to view the abstract. *This abstract was published in Pharmaceutical Development Technology, 2014 Nov 28: 1-10

 

PREPARATION AND IN VITRO EVALUATION OF A PLURONIC LECITHIN ORGANOGEL CONTAINING RICINOLEIC ACID FOR TRANSDERMAL DELIVERY

Principal Investigators: Sai HS. Boddu, PhD, Assistant Professor of Pharmaceutics, Frederic and Mary Wolfe Center, College of Pharmacy and Pharmaceutical Sciences, University of Toledo HSC, Sindhu Prabha Bonam, BS; Yangjie Wei, BS; Kenneth Alexander, PhD


Click here to view the abstract. *Published in theInternational Journal of Pharmaceutical Compounding (IJPC) May/June 2014, Volume 18, Number 3: 256-261

 

COMPOUNDED PAIN FORMULATIONS: WHAT IS THE EVIDENCE?

Principal Investigators: Scott Asbill, PhD, Professor of Pharmaceutics and Chair, Department of Pharmaceutical and Administrative Sciences, Presbyterian College School of Pharmacy; Sarah M. Sweitzer, PhD, Shuler Spigener BSc, Alfonso Romero-Sandoval, MD, PhD


Click here for the abstract. *Published in theInternational Journal of Pharmaceutical Compounding (IJPC) Jul/Aug 2014 - Volume 18, Number 4: 278-286

 

CHOIICE: The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women

Principal Investigator: Kenna Stephenson, MD, FAAFP; Associate Professor of Family Medicine; The University of Texas Health Sciences Center

 

Click here to view the abstract. *Published in theInternational Journal of Pharmaceutical Compounding (IJPC) Jan/Feb 2013, Volume 17, Number 1: 78-45

 

Click here to view the abstract. *Published inCirculation, Feb. 21; 115(8)

 

Click here to view the abstract. *Published in Labome.org, May 2013

 

POTENCY EVALUATION OF MORPHINE, BUPIVICAINE & CLONIDINE SOLUTION FOR INTRATHECAL ADMINISTRATION

Principal Investigator: Richard B. Moon, PharmD, BS, RPh, FIACP, Pharmacy Innovations


Click here to view project.

 

EVALUATION OF THE STABILITY OF ACETAMINOPHEN IN PLURONIC LECITHIN ORGANOGEL AND THE DETERMINATION OF AN APPROPRIATE BEYOND-USE DATE

Principal Investigators: Gina F. Peacock, RPh, PhD, Shenandoah University College of Pharmacy; Jurgita Sauvageot, PharmD

 

Click here for the abstract. *Published in theInternational Journal of Pharmaceutical Compounding (IJPC) Sep/Oct 2012 - Volume 16, Number 5: 428-430

 

EVALUATION OF THE STABILITY OF FLUOXETINE IN PLURONIC LECITHIN ORGANOGEL AND THE DETERMINATION OF AN APPROPRIATE BEYOND-USE DATE

Principal Investigators: Gina F. Peacock, RPh, PhD, Shenandoah University College of Pharmacy; Jurgita Sauvageot, PharmD

 

Click here for the abstract. *Published in theInternational Journal of Pharmaceutical Compounding (IJPC) May/Jun 2014 - Volume 18, Number 3: 253-255

 

EVALUATION OF THE STABILITY OF PROMETHAZINE HYDROCHLORIDE IN PLURONIC LECITHIN ORGANOGEL AND THE DETERMINATION OF AN APPROPRIATE BEYOND-USE DATE

Principal Investigators: Gina F. Peacock, RPh, PhD, Shenandoah University College of Pharmacy; Jurgita Sauvageot, PharmD

 

Click here for the abstract. *Published in theInternational Journal of Pharmaceutical Compounding (IJPC) Jul/Aug 2014 - Volume 18, Number 4: 345-347

 

EVALUATION OF THE STABILITY OF KETOPROFEN IN PLURONIC LECITHIN ORGANOGEL AND THE DETERMINATION OF AN APPROPRIATE BEYOND-USE DATE

Principal Investigators: Gina F. Peacock, RPh, PhD, Shenandoah University College of Pharmacy; Jurgita Sauvageot, PharmD, Richard T. Addo, PhD


Click here for the abstract. *Published in theInternational Journal of Pharmaceutical Compounding (IJPC) Jul/Aug 2014 - Volume 18, Number 4: 348-350

 

POTENCY EVALUATION OF ALBUTEROL, IPRATROPIUM BROMIDE AND BUDESONIDE INHALATION OVER 6 MONTHS

Principal Investigator: Richard B. Moon, PharmD, BS, RPh, FIACP, Pharmacy Innovations

 

Click here for presentation.

 

STABILITY OF TETRACYCLINE HYDROCHLORIDE IN A COMPOUNDED MIXTURE

Principal Investigators: Kathleen Martin, PhD, Jade Weaver and Amanda Jacobs; University of the Incarnate Word

 

Click here for presentation.

 

POTENCY TESTING—VARIABILITY BETWEEN ANALYTICAL TESTING LABORATORIES

Principal Investigators: Matthew J. Buderer, RPh, FIACP, and Nancy Buderer, MS, CIP, Biostatistician


Click here for the abstract. *Published in theInternational Journal of Pharmaceutical Compounding (IJPC) Jan/Feb 2009 – Volume 13, Number 1: 74-77

 

PATIENT-CENTERED CARE SERVICES IN THE COMMUNITY-BASED COMPOUNDING PRACTICE

Principal Investigator: Timothy B. McPherson, PhD, RPh, Patrick E Fontane; South Illinois University, Edwardsville School of Pharmacy and St. Louis College of Pharmacy

 

Click for presentation.

 

TRANSDERMAL AMLODIPINE BESYLATE IN LIPODERM FOR THE TREATMENT OF FELINE HYPERTENSION: A REPORT OF TWO CASES

Principal Investigators: William Mixon, MS, RPh, FIACP, Scott R. Helms, DVM

 

Click here for the abstract. *Published in the International Journal of Pharmaceutical Compounding (IJPC) Sept/Oct 2008 – Volume 12, Number 5: 392-397

 

 

 

 

DONATE TO THE FOUNDATION

 http://www.iacprx.org/resource/resmgr/Fundraising/DonateNow.jpg  

To make your gift online, please click here. Or call

the IACP Foundation offices at 281.933.8400 or email

Jennifer Petska, BS, CPhT, IACP Foundation Administrator

and Director of Development.

 

Association Management Software Powered by YourMembership  ::  Legal